Point-of-Care Testing for Infectious Diseases: Past, Present, and Future
Author(s) -
Thomas R. Kozel,
Amanda R. BurnhamMarusich
Publication year - 2017
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00476-17
Subject(s) - point of care testing , point of care , molecular diagnostics , medicine , health care , emerging technologies , data science , computer science , intensive care medicine , risk analysis (engineering) , medical emergency , pathology , bioinformatics , biology , artificial intelligence , economics , economic growth
Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system. The usual platform has been the lateral flow immunoassay. Recently, emerging molecular diagnostics have met requirements for speed, low cost, and ease of use for POC applications. A major driver for POC development is the ability to diagnose infectious diseases at sites with a limited infrastructure. The potential use in both wealthy and resource-limited settings has fueled an intense effort to build on existing technologies and to generate new technologies for the diagnosis of a broad spectrum of infectious diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom